These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28608641)

  • 1. Risk factors for Pneumocystis pneumonia after the first 6 months following renal transplantation.
    Faure E; Lionet A; Kipnis E; Noël C; Hazzan M
    Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28608641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients.
    Arend SM; Westendorp RG; Kroon FP; van't Wout JW; Vandenbroucke JP; van Es LA; van der Woude FJ
    Clin Infect Dis; 1996 Jun; 22(6):920-5. PubMed ID: 8783687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study.
    Radisic M; Lattes R; Chapman JF; del Carmen Rial M; Guardia O; Seu F; Gutierrez P; Goldberg J; Casadei DH
    Transpl Infect Dis; 2003 Jun; 5(2):84-93. PubMed ID: 12974789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past.
    Wang EH; Partovi N; Levy RD; Shapiro RJ; Yoshida EM; Greanya ED
    Transpl Infect Dis; 2012 Oct; 14(5):519-25. PubMed ID: 22571389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multicenter Case-control Study of the Effect of Acute Rejection and Cytomegalovirus Infection on Pneumocystis Pneumonia in Solid Organ Transplant Recipients.
    Hosseini-Moghaddam SM; Shokoohi M; Singh G; Dufresne SF; Boucher A; Jevnikar A; Prasad GVR; Shoker A; Kabbani D; Hebert MJ; Cardinal H; Houde I; Humar A; Kumar D
    Clin Infect Dis; 2019 Apr; 68(8):1320-1326. PubMed ID: 30107568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis.
    de Boer MG; Kroon FP; le Cessie S; de Fijter JW; van Dissel JT
    Transpl Infect Dis; 2011 Dec; 13(6):559-69. PubMed ID: 21689251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of USRDS: incidence and risk factors for Pneumocystis jiroveci pneumonia.
    Neff RT; Jindal RM; Yoo DY; Hurst FP; Agodoa LY; Abbott KC
    Transplantation; 2009 Jul; 88(1):135-41. PubMed ID: 19584693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors of Pneumocystis pneumonia in solid organ recipients in the era of the common use of posttransplantation prophylaxis.
    Iriart X; Challan Belval T; Fillaux J; Esposito L; Lavergne RA; Cardeau-Desangles I; Roques O; Del Bello A; Cointault O; Lavayssière L; Chauvin P; Menard S; Magnaval JF; Cassaing S; Rostaing L; Kamar N; Berry A
    Am J Transplant; 2015 Jan; 15(1):190-9. PubMed ID: 25496195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumocystis carinii pneumonia in renal transplant recipients.
    Branten AJ; Beckers PJ; Tiggeler RG; Hoitsma AJ
    Nephrol Dial Transplant; 1995; 10(7):1194-7. PubMed ID: 7478123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumocystis jirovecii pneumonia in renal transplant recipients occurring after discontinuation of prophylaxis: a case–control study.
    De Castro N; Xu F; Porcher R; Pavie J; Molina JM; Peraldi MN
    Clin Microbiol Infect; 2010 Sep; 16(9):1375-7. PubMed ID: 20041898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumocystis jirovecii pneumonia in renal transplant recipients: a national center experience.
    Borstnar S; Lindic J; Tomazic J; Kandus A; Pikelj A; Prah J; Skvarc M; Godnov U; Kovac D
    Transplant Proc; 2013 May; 45(4):1614-7. PubMed ID: 23726632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired thymic function and CD4+ T lymphopenia, but not mannose-binding lectin deficiency, are risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients.
    Schürmann M; Schürmann D; Schindler R; Meisel C; Liman P; Kruse J; Enghard P; König J; Schmidt D; Reinke P; Nickel P
    Transpl Immunol; 2013 Jun; 28(4):159-63. PubMed ID: 23684946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons learned from a pneumocystis pneumonia outbreak at a Scottish renal transplant centre.
    McClarey A; Phelan P; O'Shea D; Henderson L; Gunson R; Laurenson IF
    J Hosp Infect; 2019 Jul; 102(3):311-316. PubMed ID: 30802526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of Pneumocystis carinii pneumonia after renal transplantation. Impact of immunosuppression.
    Lufft V; Kliem V; Behrend M; Pichlmayr R; Koch KM; Brunkhorst R
    Transplantation; 1996 Aug; 62(3):421-3. PubMed ID: 8779695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CMV Infection and Lymphopenia: Warning Markers of
    Eberl I; Binquet C; Guilloteau A; Legendre M; Dalle F; Piroth L; Tinel C; Blot M
    Transpl Int; 2024; 37():12192. PubMed ID: 38328616
    [No Abstract]   [Full Text] [Related]  

  • 16. Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia.
    Orlando G; Tariciotti L; Manzia TM; Gravante G; Sorge R; Manuelli M; Pisani F; Di Cocco P; Scelzo C; Burke GM; Soker S; Baiocchi L; Lerut J; Angelico M; Tisone G
    Transpl Infect Dis; 2010 Feb; 12(1):11-5. PubMed ID: 19744283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Pneumocystis jiroveci pneumonia in patients long after renal transplantation.
    Struijk GH; Gijsen AF; Yong SL; Zwinderman AH; Geerlings SE; Lettinga KD; van Donselaar-van der Pant KA; ten Berge IJ; Bemelman FJ
    Nephrol Dial Transplant; 2011 Oct; 26(10):3391-8. PubMed ID: 21385859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outbreak of Pneumocystis jiroveci pneumonia in renal transplant recipients: P. jiroveci is contagious to the susceptible host.
    Yazaki H; Goto N; Uchida K; Kobayashi T; Gatanaga H; Oka S
    Transplantation; 2009 Aug; 88(3):380-5. PubMed ID: 19667941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients.
    Lee SH; Huh KH; Joo DJ; Kim MS; Kim SI; Lee J; Park MS; Kim YS; Kim SK; Chang J; Kim YS; Kim SY
    Sci Rep; 2017 May; 7(1):1571. PubMed ID: 28484270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumocystis jirovecii pneumonia is rare in renal transplant recipients receiving only one month of prophylaxis.
    Anand S; Samaniego M; Kaul DR
    Transpl Infect Dis; 2011 Dec; 13(6):570-4. PubMed ID: 22093215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.